Old Web
English
Sign In
Acemap
>
Paper
>
Phase II Trial of SGI-110 (Guadecitabine) in Philadelphia Negative Myeloproliferative Neoplasms
Phase II Trial of SGI-110 (Guadecitabine) in Philadelphia Negative Myeloproliferative Neoplasms
2019
Pinkal Desai
Niamh Savage
Spencer Krichevsky
Tania J. Curcio
Sangmin Lee
Michael B. Samuel
Ellen K. Ritchie
Gail J. Roboz
Keywords:
Oncology
Philadelphia negative
Immunology
Internal medicine
Medicine
Myelofibrosis
Accelerated phase
Philadelphia chromosome
Myeloproliferative disease
tumor cells
complete remission
Secondary Myelofibrosis
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]